查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1134553

羥氯喹的全球市場:現狀分析與預測(2022年～2028年)

Hydroxychloroquine Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球羥氯喹的市場規模在預測期間內預計將以約10％大幅度成長。市場增長可歸因於發展中國家瘧疾發病率的上升。

本報告提供全球羥氯喹市場相關調查分析，提供市場規模與預測分析，主要趨勢和機會，企業簡介等資訊。

目錄

第1章 市場簡介

第2章 調查手法·前提條件

第3章 市場摘要

第4章 摘要整理

第5章 羥氯喹市場上COVID-19的影響

第6章 羥氯喹的市場收益(2020年～2028年)

第7章 市場考察:各疾病

  • 瘧疾
  • 類風濕性關節炎
  • COVID-19
  • 其他

第8章 市場考察:各驅動器類型

  • 醫院藥局
  • 零售藥局
  • 線上藥局

第9章 市場考察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他的北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區
  • 其他地區

第10章 羥氯喹的市場動態

  • 推動市場要素
  • 市場課題
  • 影響的分析

第11章 羥氯喹市場機會

第12章 羥氯喹市場趨勢

第13章 供需分析

  • 需求端分析
  • 供應端分析

第14章 價值鏈分析

第15章 競爭模式

  • 競爭情形
    • 波特的五力分析

第16章 企業概要

  • Sanofi S.A.
  • Novartis AG
  • Pfizer Inc.
  • Cadila Pharmaceuticals Limited
  • Ipca Laboratories Limited
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited

第17章 免責聲明

簡介目錄
Product Code: UMCH211107

Global Hydroxychloroquine Market is expected to grow at a significant rate of around 10% during the forecast period. Hydroxychloroquine is a medicine that is sold under the brand name Plaquenil and is used for preventing and treating malaria in areas where malaria remains sensitive to chloroquine. It is also used in the treatment of rheumatoid arthritis, lupus, COVID-19, etc. The growth of the hydroxychloroquine market can be attributed to the rising incidences of malaria in developing nations. For instance, according to the World Malaria Report, in 2019, nearly 6 million individuals were diagnosed with malaria alone in India. Also, as per WHO, in 2020, there were an estimated 241 million cases of malaria worldwide and the estimated number of malaria deaths stood at 6,27,000. Furthermore, many leading manufacturers of hydroxychloroquine have escalated the production and sales of this medicine during the pandemic as different studies in France & U.S. have shown promising results for the COVID-19 treatment.

Sanofi S.A., Novartis AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Ipca Laboratories Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hydroxychloroquine.

 

Insights Presented in the Report:

"Amongst disease, malaria category to witness robust CAGR during the forecast period"

Based on disease, the market is segmented into malaria, rheumatoid arthritis, COVID-19, and others. The malaria segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as hydroxychloroquine is an anti-malarial drug and is widely used for treating acute attacks of malaria. Furthermore, the surging cases of malaria across the world is also one of the prominent factors contributing to the growth of the market.

"Amongst distribution channels, the hospital pharmacy to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant CAGR owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"Asia-Pacific to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of malaria cases in developing Asian countries. Further, India is also one of the largest manufacturers and exporters of hydroxychloroquine which is also driving the market in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global hydroxychloroquine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Hydroxychloroquine Market
  • 2.2. Research Methodology of the Hydroxychloroquine Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HYDROXYCHLOROQUINE MARKET

6 HYDROXYCHLOROQUINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DISEASE

  • 7.1. Malaria
  • 7.2. Rheumatoid Arthritis
  • 7.3. COVID-19
  • 7.4. Others

8 MARKET INSIGHTS BY DRIVE TYPE

  • 8.1. Hospital Pharmacy
  • 8.2. Retail Pharmacy
  • 8.3. Online Pharmacy

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 HYDROXYCHLOROQUINE MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 HYDROXYCHLOROQUINE MARKET OPPORTUNITIES

12 HYDROXYCHLOROQUINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Sanofi S.A.
  • 16.2. Novartis AG
  • 16.3. Pfizer Inc.
  • 16.4. Cadila Pharmaceuticals Limited
  • 16.5. Ipca Laboratories Limited
  • 16.6. Mylan N.V.
  • 16.7. Teva Pharmaceutical Industries Ltd.
  • 16.8. Torrent Pharmaceuticals Ltd.
  • 16.9. Sun Pharmaceutical Industries Ltd.
  • 16.10. Lupin Limited

17 DISCLAIMER